Combination of Fludarabine and Imatinib Induces Apoptosis Synergistically Through Loss of Mitochondrial Membrane Potential and Increases in Caspase-3 Enzyme Activity in Human K562 Chronic Myleloid Leukemia Cells
Loading...
Files
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Open Access Color
BRONZE
Green Open Access
Yes
OpenAIRE Downloads
OpenAIRE Views
Publicly Funded
No
Abstract
In this study, we aimed to show the synergistic apoptotic effects of imatinib/fludarabine combination in human K562 chronic myleloid leukemia (CML) cells. There was a significant increase in cytotoxicity of combination of imatinib and fludarabine as compared to any agent alone. On the other hand, combination of both agents induced apoptosis significantly as confirmed by increases in caspase-3 enzyme activity and decreases in mitochondrial membrane potential. As a summary, the results of this study strongly suggest that combination of imatinib and fludarabine induced cell death synergistically comparing to only imatinib or fludarabine in human K562 CML cells. Copyright © 2010 Informa Healthcare USA, Inc.
Description
Keywords
Apoptosis, BCR/ABL, Chronic myeloid leukemia, Fludarabine, Imatinib, Apoptosis, Piperazines, Fludarabine, Inhibitory Concentration 50, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Antineoplastic Combined Chemotherapy Protocols, Humans, BCR/ABL, Cell Proliferation, Membrane Potential, Mitochondrial, Cell Death, Dose-Response Relationship, Drug, Caspase 3, Chronic myeloid leukemia, Drug Synergism, Mitochondria, Pyrimidines, Imatinib, Benzamides, Imatinib Mesylate, K562 Cells, Vidarabine
Fields of Science
0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine
Citation
Baran, Y., Öztekin, C., and Başsoy, E. Y. (2010). Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells. Cancer Investigation, 28(6), 623-628. doi:10.3109/07357901003631056
WoS Q
Scopus Q

OpenCitations Citation Count
7
Source
Volume
28
Issue
6
Start Page
623
End Page
628
PlumX Metrics
Citations
CrossRef : 4
Scopus : 6
PubMed : 1
Captures
Mendeley Readers : 11
SCOPUS™ Citations
6
checked on Apr 29, 2026
Web of Science™ Citations
6
checked on Apr 29, 2026
Page Views
840
checked on Apr 29, 2026
Downloads
514
checked on Apr 29, 2026
Google Scholar™



